Mostly Markets
Subscribe
Stocks/Health Care/Health Care Equipment

Baxter InternationalBAX

Health Care Equipment · Deerfield, Illinois · In the S&P 500
Cheaper than peers
$23.00−2.13%After hours: $23.03 (+0.13%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 2.6% over 1 year
Baxter International over 1 yearDaily close, $, to 30 Oct 2026
$20$25Nov2026MarMayJulSep$23.00$20$25NovMarJul$23.00
Source: Nasdaq daily closes
Market value$11.89B
Price to earnings–
Forward P/E11.3x
Dividend yield0.17%
Year to date+20.4%
One year+2.6%
Next earningsNot scheduled
SectorHealth Care
52-week range (closes)
$15.80$28.35

Quality and valuation

How Baxter International compares with other health care stocks. A description, not a recommendation.

Baxter International and 7 health care equipment peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: weaker than mostValuation: cheaper than most

A weaker business than most health care companies, priced below most of them.

Baxter International trades at 11.3 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +5.3% vs +7.8%
  • Keeps less of each sale (gross margin): 30.1% vs 65.3%
  • Less profitable (operating margin): −1.9% vs 13.3%
BAX trades at 11.3x forward earnings, below the sector medianForward p/e, Health Care Equipment peers
BAX11.3xBSX13.8xBDX15.0xMDT16.1xSYK18.4xABT18.6xEW29.3xISRG37.5xSector median 19.1xBAX11.3xBSX13.8xBDX15.0xMDT16.1xSYK18.4xABT18.6xEW29.3xISRG37.5xSector median 19.1x
Source: CNBC quotes; Mostly Markets

Financials

From Baxter International's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.

Revenue grew 5.0% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0bn$1bn$2bnQ4 ’24Q2 ’25Q4 ’25$3.0bnQ3 ’26$0bn$1bn$2bnQ4 ’24Q2 ’25Q4 ’25$3.0bnQ3 ’26
Source: SEC filings
Growth slowed to +5.0% last quarterRevenue growth, year on year, %
0%2%4%6%8%Q4 ’24Q2 ’25Q4 ’255.0%Q3 ’260%5%Q4 ’24Q2 ’25Q4 ’255.0%Q3 ’26
Source: SEC filings
Operating margin was 7.6% last quarterOperating income as a share of revenue, %
−20%−10%0%Q4 ’24Q2 ’25Q4 ’257.6%Q3 ’26−20%0%Q4 ’24Q2 ’25Q4 ’257.6%Q3 ’26
Source: SEC filings
Diluted EPS was $0.57 last quarterQuarterly diluted earnings per share, $
$-2$-1$0Q4 ’24Q2 ’25Q4 ’25$0.57Q3 ’26$-2$-1$0Q4 ’24Q2 ’25Q4 ’25$0.57Q3 ’26
Source: SEC filings
Last 12 monthsBAXSector median
Revenue growth+5.3%+7.8%
Gross margin30.1%65.3%
Operating margin−1.9%13.3%

Stories on Baxter International

We haven't written about Baxter International yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Equipment, by market value.

CompanyPriceTodayYTDValue
ABTAbbott Laboratories$106.20+1.56%−15.2%$184B
ISRGIntuitive Surgical$432.01−3.73%−23.7%$150B
MDTMedtronic$96.54−0.59%+0.5%$123B
SYKStryker$291.86−6.38%−17.0%$112B
BSXBoston Scientific$41.98−1.66%−56.0%$60.84B
BDXBecton Dickinson$197.88−0.23%+27.4%$53.90B
EWEdwards Lifesciences$92.01−2.57%+7.9%$53.03B
IDXXIdexx Laboratories$551.21−4.30%−18.5%$43.42B